Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by panimjon Jan 30, 2018 6:21pm

177 Views

Post# 27466584

RE:RE:RE:RE:RE:No support - it will slide to .15

This guy is a tool saying MJ stocks are over inflated
most MJ companies haven’t even gotten started
They are trying to establish them self’s buying land getting their licences
and most are just penny stocks. Not to say when they do produce
they wont fall and stabilize till at least a few quarters or longer
making profit after every quarter, and let’s not forget
the takeovers that are going to take place.
so this tool on the video is ahead of himself way ahead

Bullboard Posts

Revolutionizing medical imaging with nanocarbon-based contrast drugs